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Abstract

Introduction

The mechanism of platelet formation is reviewed with special emphasis on the role of the cytoskeleton. The three major
theories for platelet formation are by cytoplasmic budding, cytoplasmic dissolution or pseudopod formation. Most evidence indicates that platelets form as fragments of megakaryocyte pseudopodia. Pseudopodia formation is stimulated in vitro by thrombocytopenic rabbit plasma. It is inhibited by vincristine and altered
by taxol. Cytochalasins cause pseudopodia to form in isolated
megakaryocytes. Therefore, normal pseudopodia formation may
depend on a combination of microfilament disorganization and
microtubule elongation.

The formation of blood platelets by fragmentation of
megakaryocyte cytoplasm was postulated over 80 years ago (92),
yet the mechanism by which platelets form is still not completely
understood. This paper will review current knowledge on the
mechanism of platelet formation based on the numerous studies
since Wright's observations. In addition, a model for the process
of platelet formation will be presented with an emphasis on the
role of cytoskeletal elements in morphogenesis.
Wright's identification of megakaryocytes as the source of
platelets was based on the similar staining of megakaryocyte and
platelet cytoplasm, and by the presence of megakaryocyte cytoplasmic processes which appeared to be precursors of formed
platelets. Wright described platelet formation as occurring "in
various ways but usually by the pinching off of small rounded
projections or pseudopods from the cell body or from larger pseudopods, or by segmentation of slender pseudopods, or by the
pinching off of longer or shorter pseudopods. which may or may
not undergo segmentation later" (93).
Morphology of Platelet Formation
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The formation of pseudopods by megakaryocytes and their
fragmentation into platelets was soon confirmed by other investigators ( 11, I 2, 73), although Brown ( 11) believed platelets may originate from cells other than megakaryocytes under pathological
conditions.
The introduction of electron microscopy allowed the confirmation of earlier observations with the light microscope. Three
different zones of the cytoplasm, first noted by Heidenhan (33),
were described at the ultrastructural level: a peripheral organelle
free zone, a central zone dominated by membranes and granules
and an inner perinuclear zone were observed (94). The functional
significance of these cytoplasmic divisions is still not entirely
clear. The organization of the megakaryocyte cytoplasm into
membrane delineated platelet territories was first reported by
Kautz and DeMarsh (40). A detailed description of the development of these membranes, called the demarcation membrane system (DMS), soon followed (94). The discovery of the demarcation system along with histological (12,73,92,93), histochemical
(95), and immunologic (I 9,35,86) similarities between megakaryocytes and platelets established with little doubt that platelets originate as fragments of megakaryocyte cytoplasm. The demarcation
membrane system was originally thought to be derived from the
endoplasmic
reticulum
or
the
Golgi
apparatus
(18,27,31,62,63,64,71,94) or from a membrane system distinct
from any other in the cell (28). Based on MacPherson's observations (55) it is now generally accepted that invagination of the
plasma membrane gives rise to the DMS. Behnke's demonstration of the continuity of the extracellular space and the DMS
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space (5) further supports this idea. The similarity of the DMS
and plasma membrane was first implied by the observation that
virus particles in megakaryocytes bud only from the plasma membrane and DMS (17) but not other membranes. More recent studies using freeze fracture and immunological
techniques
(8,41, 74, 75,97) have provided conflicting evidence on the similarity of the DMS and megakaryocyte plasma membrane. Tavassoli
(78) and Bentfeld-Barker and Bainton (8) did not observe any
difference in the intramembrane particle distribution in platelet
and megakaryocyte plasma membranes. Zucker-Franklin, however, found that the distribution of intramembranous particles is
similar in the DMS and the platelet plasma membrane, but different from the distribution of these particles in the megakaryocyte plasma membrane (97). In addition it was found that certain
antiplatelet antisera do not react with megakaryocytes (75), implying a biochemical difference between the platelet and megakaryocyte plasma membrane. Based on these studies two conclusions
are possible. If the DMS originates from the megakaryocyte
plasma membrane, structural and biochemical changes occur
which distinguish these two membranes. The second possible
conclusion is that the megakaryocyte demarcation membrane does
not arise from the plasma membrane but becomes continuous
with it during maturation. The precise relationship between the
DMS and plasma membranes remains to be fully understood as
well as the role of the DMS in delineating future platelets.
Although it has generally been assumed that the DMS delineates
individual platelets this function of the DMS has not been universally accepted. Murata (59) has proposed that platelets form by
blebs or pseudopodia which are delineated by the megakaryocyte
plasma membrane and the DMS remains within the platelet as the
surface connected canalicular system. This is not supported by
Zucker-Franklin's finding as discussed above. It has also been
postulated that the DMS may provide a source of stored membrane used to form long pseudopodia (67,68).

fragmentation of the pseudopodia into smaller fragments was not
observed in any of these studies. We have recently found that
both guinea pig and rat megakaryocytes isolated from bone marrow are induced to form pseudopodia in vitro by the plasma from
thrombocytopenic rabbits (50); a source of thrombopoietin
activity (22) (Fig. la). Unlike previous studies, it was common to
find small fragments of detached cytoplasm similar in appearance
to proplatelets (4) or stress platelets of thrombocytopenic animals
(82) (Fig. 1b,c). In addition, the fragments contained microtubule
rings (50), providing evidence that the cytoplasm in the fragments
is organized as in normal platelets.
Megakaryocytes in vitro have also been observed to undergo
a dissolution into small fragments without pseudopodia formation
(1,66,97), and it has been postulated that this may occur only in
8N megakaryocytes (65). If this occurs in vivo it implies either
large or small fragments of megakaryocyte cytoplasm must
migrate independently across the endothelium into the circulation.
There is evidence that platelets have migratory capability (54,85),
therefore it is possible that megakaryocyte fragments are also
capable of migration, although direct evidence is lacking.
Another mechanism that has been postulated is the budding
of platelets from the surface of megakaryocytes. Several investigators (3, 13,20,36,59,84) have observed blebs on the surface of
megakaryocytes by scanning electron-microscopy.
Yet, accompanying transmission electron micrographs have failed to show
platelet organelles within the blebs (20,59). Therefore, there is no
compelling evidence to indicate platelets form in this manner. It
may be that blebs are transient structures which form as the surface of the megakaryocyte alters, but do not separate from the
megakaryocyte as platelets.
One area which should be mentioned but cannot be covered
in depth in this review is the role of pulmonary megakaryocytes in
platelet formation. Megakaryocytes were first observed in the pulmonary circulation by Aschoff (2). Howell and Donohue (34) first
postulated that platelet formation may occur in the lungs by
megakaryocytes which become trapped in the pulmonary capillaries. Since this time, studies showing a lower platelet count in
pulmonary arterial blood than pulmonary venous blood have suggested that platelet formation may occur in the lung (16,39,8 I ,83).
Work from Barnhart's laboratory has shown pulmonary
megakaryocytes which appeared to be forming platelets, based on
the appearance of surface blebs and delineation of platelet areas by
the DMS. Yet no actual fragmentation was observed and the precise mechanism of cytoplasmic fragmentation could not be determined (3,88,89,90). It seems likely that megakaryocytes normally
occur in the pulmonary capillary bed, but the extent to which
these megakaryocytes contribute to the maintenance of the circulating platelet population remains controversial.

Mechanisms of Platelet Formation
Fragmentation of megakaryocytes into platelets has been
proposed to occur by three mechanisms, pseudopod formation,
cytoplasmic dissolution, and budding. The formation of pseudopodia, first described by Wright has been observed by others
(I ,6, 10, I 8,23,26,27,42,59,64, 74). It was noted that small pseudopodia, or blebs, extend through the endothelium as an extension
of the peripheral cytoplasmic zone and contain no organelles
(64, 78). Consequently, their role in platelet formation was
unclear. Microcinematographic studies of bone marrow in situ
could not confirm a role for pseudopodia formation in the fragmentation of megakaryocytes (43). It was observed that intact
megakaryocytes traversed the endothelium, but no pseudopodia
were seen. Large pseudopodia extending through the endothelium
have also been described (26,27,64). In these studies it was noted
that pseudopodia containing a core region with a full complement
of cytoplasmic organelles could give rise to platelets upon release
from the main cell mass. Similar observations (6,42,59,65) have
confirmed the existence of pseudopodia containing platelet
organelles. Several scanning electron microscope studies have
shown long cytoplasmic processes with regularly spaced constrictions extending from extravascular megakaryocytes into venous
sinsoids (4,29,32,67). Since megakaryocytes can migrate intact
across the vessel wall (43,79,96), it is possible that pseudopodia
formation represents the initial movement of megakaryocytes into
venous sinusoids rather than an intermediate step in platelet formation.
The formation of pseudopodia by megakaryocytes can also
be observed in vitro. Several studies (I ,30,37,51 ,67,80) have
shown that outside the confines of the bone marrow, megakaryocytes are still capable of forming pseudopodia. Megakaryocytes in
bone marrow suspension were observed to spontaneously form
multiple pseudopodia which became beaded in appearance, but

Megakaryocyte Cytoskeleton
The cytoskeleton refers to structures based on the three cellular filamentous systems: microtubules, microfilaments and intermediate filaments.
The distribution
of microtubules
in
megakaryocytes has been described as random throughout the
cytoplasm (6,10,25,47,72) (Fig. 2). Microtubules have also been
seen forming aligned bundles in pseudopodia of megakaryocytes
both in vivo (6, I 0) and in vitro (50,67). Studies using vincristine
show that this drug causes pseudopodia to retract, indicating that
they are supported by microtubules (68) (Fig. 3). The role of
microtubules in supporting pseudopodia can also be demonstrated
using the drug taxol. We have found that taxol, as in other cells,
causes bundling of microtubules into large aggregates (Fig. 4).
Under conditions for pseudopodia formation in vitro, taxol causes
megakaryocytes to form a small number of very thick pseudopodia rather than several fine pseudopodia (Fig. 5). Consequently,
the organization of microtubules is a determinant of pseudopodia
formation. Immunofluorescence studies have confirmed that
most microtubules are randomly oriented (47), however 17% of
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Figure 2. Megakaryocyte microtubules. Section of a guinea pig
megakaryocyte in vitro showing multiple microtubules (arrows), in
an apparently random orientation. Bar = 250 nm.
observed megakaryocytes contained microtubule rings in their
cytoplasm. These rings are the same dimension as the platelet
marginal microtubule coil (Fig. 6). Microtubule rings are also
seen in megakaryocyte pseudopodia and proplatelets in vitro (50).
Recently it has been demonstrated that the 210 K dalton microtubule associated protein (210 K MAP) is present in human platelets
(69). Consequently, it is probable this protein is also in
megakaryocytes. It has been postulated that this protein may link
the microtubule coil to other elements of the cytoskeleton. The
210 K MAP may also play a role in the formation of the microtubule coil in megakaryocytes.
The presence of actomyosin in megakaryocytes was established using immunofluorescence microscopy (60) and shonly
thereafter, microfilaments were observed in both the peripheral
and intermediate zone of megakaryocytes (7, 10). Heavy meromyosin labeling in glycerinated cells confirmed the actin composition of the filaments (7). By use of immunofluorescent staining,

Figure 1. Rat megakaryocyte fragmentation in vitro. Isolated rat
megakaryocytes incubated for 18 h with 5 mg/ml of the 60%-80%
ammonium sulfate fraction of thrombocytopenic rabbit plasma.
a) Megakaryocyte in which the cytoplasm has almost entirely
separated into long proplatelets or pseudopodia. Beading along
the pseudopodia is evident.
b) Proplatelet fragments separating from the nucleus (large arrow).
Many proplatelets have begun breaking into small platelet like
fragments (small arrows).
c) Proplatelet fragments floating in the culture medium which are
no longer associated with any cell nucleus. a, b and c, Bar
= l00µm.

Figure 3. Vincristine inhibition of megakaryocyte fragmentation.
A megakaryocyte which had begun to form several pseudopodia,
as in Fig. la, was incubated with I0µm vincristine for I h. The
pseudopodia have rounded up and retracted. Bar= 20µm.
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Figure 4. Microtubule bundles induced by taxol. Megakaryocytes were treated with lOµm adenosine diphosphate (ADP) to
induce spreading; which allows better visualization of cytoskeletal
structures. After 30 minutes exposure to ADP, lOµm taxol was
added for an additional 24 h prior to staining with antitubulin
antibody. Large bundles of microtubules are seen. Bar = 20µm.

Figure 7. Intermediate filaments in megakaryocytes.
Section of
a megakaryocyte spread in culture after exposure to lOµm ADP.
An area with many intermediate filaments is shown. Bar = 250
nm.

Figure 5. Effect of taxol on megakaryocyte fragmentation.
Isolated rat megakaryocytes in vitro, incubated with 5 mg/ml of the
60%-80% ammonium sulfate fraction of thrombocytopenic rabbit
plasma and 1Oµm taxol. Instead of numerous fine pseudopodia, a
few very large pseudopodia form. Bar= lOOµm.

Figure 8. Spread megakaryocyte fragments. Thin section of fragments from a megakaryocyte induced to spread with lOµm ADP.
The fragments are lacking granules, mitochondria and microtubules, and contain only peripheral zone cytoplasm. Bar = l.Oµm.

Figure 6. Microtubule
rings
in
megakaryocytes.
Isolated
megakaryocyte, spread in response to lOµm ADP followed by
staining with anti-tubulin antibody. Several microtubule rings can
be seen (arrows). These rings may represent newly forming platelet microtubule coils. bar = 20µm
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myosin, filamin and alpha-actinin have also been demonstrated to
be components of the megakaryocyte cytoskeleton (47). These
proteins are arranged in a discontinuous fashion along actin based
filaments, similar to stress fiber structure (46). Several actin associated regulatory proteins have been characterized in blood platelets (44,45,56,70,87). Two of these proteins, actin binding protein
and alpha-actinin, are known to be in megakaryocytes (47), and
the others most likely are as well. These proteins control the
organization of actin in other cells but their function in
megakaryocyte motility is not known. A possible role for these
proteins in platelet formation is discussed below.
Intermediate filaments have only recently been observed in
blood platelets (77) and we have now observed intermediate filaments in megakaryocytes (Fig. 7). The function of intermediate
filaments is still unresolved and their role in megakaryocytes and
platelets is unclear.

c)

Megakaryocyte Motility
Studies on pseudopod formation, as previously discussed
clearly demonstrate
the motile nature of megakaryocytes.
Megakaryocytes in culture show a motile response to platelet
activators by ruffiing and spreading (24,38,47). Megakaryocyte
spreading is associated with a change in microfilament organization and adherence of the cell. Platelet activators also alter the
electrophysiological properties of the megakaryocyte membrane
(48).
In addition to platelet activators, megakaryocyte morphology
is altered by extracellular
matrix components.
Isolated
megakaryocytes cultured on collagen and fibronectin coated dishes
(47) or on endothelial cell extracellular matrix (52) spread the
same as cells exposed to platelet activators. Megakaryocytes in
vivo are in close contact with the endothelium (53,57,91 ). The
close contact may be maintained by the strong affinity of
megakaryocytes for extracellular matrix components as observed
in vitro. Under certain conditions megakaryocytes which spread
on extracellular matrix coated dishes break into platelet sized fragments (52). Our own studies of spread cells show that they occasionally fragment, but the fragments are devoid of organelles
(Fig. 8). Therefore it is not clear to what extent this mode of fragmentation represents platelet formation.

Figure 9. Model of megakaryocyte fragmentation. MT = microtubules, MF = microfilaments.
Lightly stippled area illustrates
intermediate zone cytoplasm. Darkly stippled area illustrates peripheral zone cytoplasm.
a) Megakaryocyte before pseudopod formation, small blebs of the
peripheral zone are in close contact with the endothelium. Microfilaments are intact in the peripheral zone and numerous microtubules course through the central region cytoplasm.
b) With the initiation of pseudopod formation the microfilaments
are disassembled in the peripheral zone around the elongating
pseudopods.
A core of central region cytoplasm containing
organelles and supporting microtubules is in the center of each
pseudopod.
c) The peripheral zone becomes very diminished and demarcation
membrane spaces have become more dilated as platelet-formation
continues. Pseudopodia are beginning to break into smaller fragments and microtubule coils form in pseudopodia and in nascent
platelets. Further details are in the text.
increased during thrombocytopenia, to mature megakaryocytes.
This may be facilitated by the extension of small cytoplasmic
blebs across the endothelium where the megakaryocyte could
directly detect a change in circulating thrombopoietin, as postulated by Tavassoli (78). The initial stage in pseudopod formation
we propose to be the disassembly of actin filaments or filament
networks in the peripheral zone nearest the endothelium causing
the cytoplasm of this zone to become more liquid (solation), as
described by Condeelis and Taylor (14). This could occur by a
change in binding of actin binding protein, alpha-actinin or other
actin associated proteins which influence the state of actin. We
base our assumption of a change in the state in actin on our recent
study with cytochalasin (50). We found that incubation of
megakaryocytes in vitro with cytochalasin B or D caused pseudopodia formation. Therefore, actin filament disassembly, the primary action of cytochalasins, is sufficient to initiate pseudopod
formation. The weakened cytoplasm of the peripheral zone may
actually break and fragment as appears to occur in the study by
Zucker-Franklin (97). Concurrently, cytoplasmic microtubules
form the core of pseudopodia which push through the weakened
peripheral zone into the venous sinusoid either by reorganization
or polymerization of the microtubules. The direction of pseudopod formation and the number of pseudopodia could be controlled by initial restriction of peripheral zone solation to small
areas near the endothelium. Fusion of the DMS causes separation
of the cytoplasm into long proplatelet structures which continue as
part of the pseudopodia into the circulation. An alternate mechanism for the determination of pseudopod number has been proposed by Radley (67). Based on the observation of multiple centrioles in megakaryocytes (9,58) it was proposed that centrioles

Regulation of Megakaryocyte Fragmentation
and Model of Platelet Formation
There is limited evidence that the final stage of megakaryocyte maturation, the formation of platelets, is hormonally controlled. Odell et al. (61) showed that platelet size increased in
thrombocytopenic rats within 18 h after the injection of antiplatelet antiserum. This has recently been confirmed by Corash, et al.
( 15). Since the time of transit through the final stage of
megakaryocyte maturation is 24-42 h (21) these results can only
be explained by an alteration of the most mature megakaryocytes
in the thrombocytopenic state. This may be through the increase
of circulating thrombopoietin activity, which occurs in thrombocytopenia (22). Also, Straneva et al. (76) have provided evidence
that serum from aplastic anemia patients may increase the rate of
cytoplasmic maturation
of isolated human megakaryocytes.
Finally, our study of guinea pig megakaryocytes shows that thrombopoietin enriched rabbit plasma stimulates the fragmentation of
megakaryoctyes in vitro (49,50). Consequently, it appears that the
morphological alterations which occur during platelet formation
can be induced by a circulating agent which increases concentration during thrombocytopenia.
The mechanism by which this
agent triggers the intracellular events leading to fragmentation is a
problem which requires further research.
Figure 9 summarizes our model of the role of cytoskeletal
elements in pseudopod formation and platelet release from
megakaryocytes. We propose that the initial stimulus to pseudopod formation is the binding of a circulating agent, which is
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17. Dalton AJ, Law LW, Moloney JB, Manaker RA (1961)
An electron microscopic study of a series of murine lymphoid
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I 8. De Bruyn PPH ( 1964) The fine structure of the
megakaryocyte of the bone marrow of the guinea pig. Zeit. fur
Zellforsch. 64, 111- I 18.
19. De Leval M ( 1967) Mise en evidence d' antigen es plaquettaire dans le cytoplasme des megacaryocytes par la technique
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Biol. (Paris) 161, 948-951.
20. Djaldetti M, Fishman P, Bessler H, Nett I (I 979) SEM
observations
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21. Ebbe S, Stohl man Jr, F ( 1965) Megakaryocytopoiesis in
the rat. Blood 26, 20-35.
22. Evatt BL, Shreiner RP, Levin J (I 974) Thrombopoietic
activity of fractions of rabbit plasma: studies in rabbits and mice.
J. Lab. Clin. Med. 83, 364-371.
23. Falcao L, Gautier A (I 967) Recherches ultrastructurales
sur la liberation des plaquettes par Jes megacaryocytes humains.
Blut 16, 57-64.
24. Fedorko ME ( 1977) The functional capacity of guinea
pig megakaryocytes. I. Uptake of 3 H-serotonin by megakaryocytes
and their physiologic and morphologic response to stimuli for the
platelet release reaction. Lab. Invest. 36, 3 I 0-320.
25. Fedorko ME ( 1978) Morphologic and functional observations on bone marrow megakaryocytes. In: The Year in Hematology. Gordon AS, Silber R, LoBue J (eds.) Plenum, NY,
171-209.
26. French JE (I 967) Blood platelets: Morphological studies
on their properties and life cycle. Br. J. Haemat. 13, 595-603.
27. Gautier A, Jean G, Probst M, Falcao L (I 963) Ultrastructure du megacaryocyte et problemes de plaquettogenese.
Arch. Ital. Anat. Istol. Pat. 37, 503-521.
28. Geyer G, Schaaf P ( I 972) The megakaryocyte demarcation membrane (DM)-endoplasmic or superficial origin? Acta.
Histochem. 44, 137-143.
29. Haller CJ, Radley JM (1983) Time-lapse cinematography and scanning electron microscopy of platelet formation by
megakaryocytes. Blood Cells 9, 407-4 I 8.
30. Ham AW Cormack DH (1979) Histology. J.B. Lippincott, Toronto, p. 317-320.
3 I. Han SS, Baker BL (1964) The ultrastructure
of
megakaryocytes and blood platelets in the rat spleen. Anat. Rec.
149, 251-268.
32. Handagama P, Jain NC, Kono CS, Feldman BF (I 986)
Scanning electron microscopic studies of megakaryocytes and
platelet formation in the dog and rat. Am. J. Vet. Res. 47,
2454-2460.
33. Heidenhan M (1894) Neve Ontersuchungen Uber die
zentralkoL:rper und ihre Beziehungen zum kern-unl Zellerprotoplasma. Arch. Mikrosk. Anat. 43, 423-758.
34. Howell WA, Donahue DD (1937) The production of
blood platelets in the lung. J. Exp. Med. 65, 177-203.

direct the location and direction of pseudopod growth. Since centriole number may be related to ploidy, it is a consequence of the
model that the number of pseudopodia would be affected by the
ploidy.
The beading of proplatelets (4), we believe, occurs as a result
of microtubule coil formation, a process which may begin prior to
pseudopod formation (Fig. 6). Microtubule coil formation may
therefore be a critical determinant of platelet size. The constriction of cytoplasm between nascent platelets cannot occur by an
actomyosin contraction since fragmentation occurs in the presence
of cytochalasins. Although highly speculative, we propose that
interaction of the forming microtubule coil and the plasma membrane possibly through other elements of the cytoskeleton may
draw the membrane into a beaded configuration. How the final
fragmentation between platelets occurs remains unknown.
This model attempts to explain one mechanism by which
platelets arise from megakaryocytes.
Though incomplete, we
believe this model to be useful as a basis to direct future research.
We cannot exclude the possibility that platelets also form by a
rapid dissolution of the entire megakaryocyte cytoplasm, or by the
shedding of cytoplasmic blebs.
Though we are beginning to understand the role of the
cytoskeleton in pseudopod formation, we expect further studies on
the distribution of microfilament and microtubule associated proteins will help explain how cytoskeletal rearrangements occur in
megakaryocytes. Of particular interest is how the microtubule coil
forms and what relationship may exist between microtubules and
the cell membrane. The recent development of an in vitro system
to study fragmentation of isolated megakaryocytes (50) will allow
for continued unraveling of the complex process of platelet formation.
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M.E. Fedorko: Are you sure the tissue culture conditions do not
contribute to what you see in the in vitro system, such as the presence of silicon or glass, inhibitors or serum?
Author: I do not believe these factors are involved. We see the
same morphological response on glass or plastic surfaces and at
varying concentrations of inhibitors. Also, there are no siliconized surfaces in the cultures.

M.E. Fedorko: How are your in vitro preparations obtained and
prepared?
Author: Guinea pig and rat megakaryocytes are obtained by slight
modification (47) of the technique of Levine and Fedorko (101).
The cells are maintained in liquid culture using Dulbbecos modified Eagle medium and 10% fetal calf serum. Thrombocytopenic
plasma or control plasma fractions are added at 1- IO mg/ml and
cultures are incubated up to 45 hours. These conditions are
described in detail in Leven and Yee (50).

M. Fedorko: How do you explain the in vivo effect of vincristine
which is used clinically to increase platelet levels?.
Author: The increase in platelet count seen in vivo after vincristine injection is not inconsistent with our model. In response to
vincristine it has been shown by Ebbe et al. (99) and by Choi et al.
(98) that there is an initial decrease in both platelets and
megakaryocytes. This is entirely consistent with our interpretation of platelet formation. Thrombocytosis occurs only several
days later, apparently as an overcompensating response to the initial depletion of the megakaryocyte and platelet population.

D.B. Warheit: What are the major difficulties and drawbacks
associated with describing mechanisms of platelet formation in
vivo based upon studies carried out under culture conditions?
Author: The obvious problem is that one cannot reconstruct in
vitro the complex in vivo environment
of the bone marrow,
though to do so would not necessarily be desirable. By analyzing
a simple in vitro system it should be possible to determine the
relative importance of different components
of the marrow
environment.
These components include circulating factors, such
as thrombopoietin, hematopoietic cells, stromal cells, endothelial
cells and the endothelial basement membrane. The relationship
to the basement membrane is of special interest due to the proximity of megakaryocytes
to the marrow endothelium.
As
described in this paper megakaryocytes in vitro adhere to and
spread on basement membrane components. It would be interesting to know if an in vivo counterpart to this activity exists. I
believe that in vitro studies can best be used as a guide for what
may occur in vivo, and to then test the in vitro models as best as
possible in the intact animal.

Discussion with Reviewers
M. Tavassoli: The blebs that are seen in SEM and are devoid of
platelet organelles in TEM have been the subject of speculation
for many years. In view of the perisinal position of megakaryocytes in the marrow, could these blebs serve as an "anchoring"
mechanism whereby the cell is fixed to the endothelial wall? The
fact that the cell is otherwise motile makes this possibility even
more plausible.
Author: I agree that the surface blebs may assist in attachment of
megakaryocytes to the sinus wall in the bone marrow. In vitro
studies have shown (47,52) that megakaryocytes are very adherent
to components of the basement membrane, collagen, fibronectin
and laminin. Unfortunately we still know very little about the in
vivo activities of megakaryocytes.
I would like to speculate that
the blebs may be a means by which the megakaryocytes probe the
sinus wall for sites which will best allow the passage of the
megakaryocyte cytoplasmic extension across the endothelium into
the circulation.

D.B. Warheit: What experiments could be carried out to determine whether the demarcation membrane system is derived from
the megakaryocyte plasma membrane?
Author: This is a particularly interesting and particularly difficult
problem. At present I do not know of any experiment that would
definitively answer this question. One approach would depend on
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immunologic detection of distinct demarcation
membrane
antigens. One could then label the demarcation membranes and
using tannic acid or ruthenium red, attempt to see if the demarcation membrane is or is not always continuous with the extracellular space.
D.B. Warheit: How convincing is the data that platelet formation
occurs as a result of cytoplasmic dissolution? Based on the
current data, what are the strengths and weaknesses of this proposed mechanism?
Author: The evidence that platelets could form in the marrow by
rapid dissolution of the megakaryocyte into platelet sized fragments is limited. It is difficult to explain how these small fragments could cross the endothelium into the circulation. As far as
I know, no ultrastructural evidence exists to show such a process
occurs. In contrast, if platelet formation occurs in pulmonary
capillaries it seems reasonable that a rapid dissolution of the
megakaryocyte into platelets could occur since migration across
the endothelium would not be necessary.
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